Literature DB >> 27565159

Beverage consumption and paediatric NAFLD.

Antonella Mosca1, Claudia Della Corte2, Maria Rita Sartorelli2, Francesca Ferretti2, Francesco Nicita3, Andrea Vania4, Valerio Nobili2.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents, due to the increased worldwide incidence of obesity among children. It is now clear enough that of diet high in carbohydrates and simple sugars are associated with hepatic steatosis and non-alcoholic steatohepatitis (NASH). Several studies have shown that an increased consumption of simple sugars is also positively associated with overweight and obesity, and related co-morbidities, such as type 2 diabetes, metabolic syndrome and NAFLD. It is difficult to define the role of the various components of soft drinks and energy drinks in the pathogenesis of NAFLD and its progression in NASH, but the major role is played by high calorie and high sugar consumption, mainly fructose. In addition, other components of these beverages (e.g. xanthine) seem to have an important role in the pathogenesis of metabolic disorders, crucial pathways involved in NAFLD/NASH. The drastic reduction in the consumption of energy drinks and soft drinks is an appropriate intervention for the prevention of obesity and NAFLD in young people.

Entities:  

Keywords:  Adolescents; Alcohol; Energy drinks; Fructose; NAFLD; Soft drinks

Mesh:

Year:  2016        PMID: 27565159     DOI: 10.1007/s40519-016-0315-3

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  42 in total

1.  Prediction of non-alcoholic fatty liver disease by obesity indices.

Authors:  Tomoyuki Kawada
Journal:  Eat Weight Disord       Date:  2015-09-21       Impact factor: 4.652

2.  Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis.

Authors:  Jeffrey W Molloy; Christopher J Calcagno; Christopher D Williams; Frances J Jones; Dawn M Torres; Stephen A Harrison
Journal:  Hepatology       Date:  2011-12-22       Impact factor: 17.425

3.  Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children?

Authors:  Mehmet Emre Atabek; Beray Selver Eklioglu; Nesibe Akyürek
Journal:  Eat Weight Disord       Date:  2014-05-21       Impact factor: 4.652

4.  Consumption of energy drinks, alcohol, and alcohol-mixed energy drinks among Italian adolescents.

Authors:  Domenico Flotta; Rocco Micò; Carmelo G A Nobile; Claudia Pileggi; Aida Bianco; Maria Pavia
Journal:  Alcohol Clin Exp Res       Date:  2014-04-09       Impact factor: 3.455

Review 5.  A 360-degree overview of paediatric NAFLD: recent insights.

Authors:  Valerio Nobili; Gianluca Svegliati-Baroni; Anna Alisi; Luca Miele; Luca Valenti; Pietro Vajro
Journal:  J Hepatol       Date:  2012-12-10       Impact factor: 25.083

6.  Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK.

Authors:  Jun Xu; Keane K Y Lai; Alla Verlinsky; Aurelia Lugea; Samuel W French; Marcus P Cooper; Cheng Ji; Hidekazu Tsukamoto
Journal:  J Hepatol       Date:  2011-01-21       Impact factor: 25.083

7.  How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations.

Authors:  Jonathan A Dranoff; Jordan J Feld; Elise G Lavoie; Michel Fausther
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

Review 8.  Dietary fructose in nonalcoholic fatty liver disease.

Authors:  Miriam B Vos; Joel E Lavine
Journal:  Hepatology       Date:  2013-05-01       Impact factor: 17.425

9.  Binge drinking among US adults.

Authors:  Timothy S Naimi; Robert D Brewer; Ali Mokdad; Clark Denny; Mary K Serdula; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

10.  Acute Liver Failure Following One Year of Daily Consumption of a Sugar-Free Energy Drink.

Authors:  Brian Huang; David Kunkel; Mohamed El Kabany
Journal:  ACG Case Rep J       Date:  2014-07-08
View more
  6 in total

Review 1.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Authors:  Thomas Jensen; Manal F Abdelmalek; Shelby Sullivan; Kristen J Nadeau; Melanie Green; Carlos Roncal; Takahiko Nakagawa; Masanari Kuwabara; Yuka Sato; Duk-Hee Kang; Dean R Tolan; Laura G Sanchez-Lozada; Hugo R Rosen; Miguel A Lanaspa; Anna Mae Diehl; Richard J Johnson
Journal:  J Hepatol       Date:  2018-02-02       Impact factor: 25.083

Review 2.  Impact of Energy Drinks on Health and Well-being.

Authors:  Senthilkumar Sankararaman; Wahid Syed; Valentina Medici; Thomas J Sferra
Journal:  Curr Nutr Rep       Date:  2018-09

3.  When the beverage is sweet, how does the liver feel?

Authors:  Dong Xi; Rohit Kohli
Journal:  Curr Treat Options Pediatr       Date:  2019-11-11

Review 4.  Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.

Authors:  Kasper W Ter Horst; Mireille J Serlie
Journal:  Nutrients       Date:  2017-09-06       Impact factor: 5.717

Review 5.  Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age.

Authors:  Elisa Russo; Giovanna Leoncini; Pasquale Esposito; Giacomo Garibotto; Roberto Pontremoli; Francesca Viazzi
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

Review 6.  Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease.

Authors:  Gigliola Alberti; Juan Cristóbal Gana; José L Santos
Journal:  Nutrients       Date:  2020-11-17       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.